Explore ALPCO's Diverse Products for Gastroenterology Research
AGA Guidelines: Calprotectin and C-Reactive Protein Monitoring for the Management of Crohn’s Disease
Download our infograhpic prepared by ALPCO and gain a comprehensive overview of the American Gastroenterological Association (AGA) guidelines, offering a new perspective on managing Crohn's Disease using biomarkers.
Key highlights include the guideline panel's 11 conditional recommendations, particularly focusing on the use of a biomarker- and symptom-based monitoring strategy. It clarifies the significance of fecal calprotectin and CRP levels in assessing disease activity and guiding the need for endoscopic evaluation.
[Infographic] Biomarker Monitoring for the Management of Crohn’s Disease
Spotlight: Immunoturbidimetric Assay for Fecal Calprotectin
Extraction to Results – Simplify Complexity
Leverage the power of our FDA-Cleared Immunoturbidimetric (IT) Assay for fecal calprotectin designed to integrate seamlessly with your existing clinical chemistry analyzer. Experience a method that is not only time and cost-efficient but also a viable alternative to conventional and send-out methodologies.
GET YOUR TIME BACK
Upgrading to ALPCO’s Immunoturbidimetric solution for calprotectin testing offers a 40%-65% reduction in time to first result compared to leading Flash Chemiluminescence automated systems.
ACCURACY
ALPCO’s Calprotectin IT Assay combines the clinical sensitivity and specificity clinicians expect with the efficiency and repeatability today’s laboratories require.
MAXIMIZE THROUGHPUT
Increase throughput by more than 57% when comparing tests per hour from a leading CLIA system to ALPCO’s Immunoturbidimetric assay running on a clinical chemistry analyzer.
COST SAVINGS
Realize a savings of up to 87% on the cost per test when comparing the average send-out cost to ALPCO’s in-house cost per test.
Ready to Schedule Your Free Evaluation?
See for yourself why labs are switching to ALPCO’s new FDA-cleared Calprotectin Immunoturbidimetric Assay.
One free kit per laboratory. Void where prohibited.
Simplicity, Efficiency, and Cost Effectiveness, All While Elevating Confidence in Your Results.
FAQs
The calprotectin immunoturbidimetric assay (80-CALPHU-IT200, -100) is 510(k)-cleared in the U.S., IVDD in the EU, and has been submitted for review by Health Canada.
It is recommended to run calibrators once per month and with every kit lot change. Two controls are typically run each day calprotectin testing is performed.
Unlike traditional ELISA, which could have up to 22 non-reportables per run (8 calibrators and 3 controls in duplicate), the immunoturbidimetric assay requires only two non-reportables (2 controls) per day, easily accommodating low volume to high volume testing at a competitive cost per test.
Follow ALPCO on Social Media
Stay up to date with new products, articles, and events.